Clinical Trial Update: A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer [Phase 2]

View source ↗

Summary

A randomized phase 2 trial evaluating ixabepilone plus carboplatin and paclitaxel plus carboplatin in advanced non-small cell lung cancer has been completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Ixabepilone (ixabepilone)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: R-Pharm | Conditions: Advanced/Metastatic Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-10-17